IPA expands its scope of work

The International Probiotics Association (IPA) announces a major expansion of its scope to include the “biotics” categories of prebiotics, postbiotics, and synbiotics within the human, infant, and companion animal segments of food and dietary supplements.

The IPA Board of Directors voted to expand the association’s scope to complement its historical focus on probiotics. The expansion is part of the organization’s strategy to help the ’biotics’ industry grow in response to market demands and strengthen its ownership within the ‘biotics’ categories.

The move will not impede IPA’s focused efforts regarding the probiotics category but, rather, it will only strengthen the organization’s efforts. “We are better together” said Amy Smith, the newly appointed IPA President.

IPA will work on building the required frameworks and organizational structure to ensure a successful future for the probiotics, prebiotics, postbiotics and synbiotics industry.

“It is a natural progression for the evolution of IPA, and we are delighted to announce this expansion in strategic focus”, said George Paraskevakos, Executive Director, IPA. “We will continue our solid path of driving and advancing the probiotic category as we replicate our past achievements in these additional ‘biotic’ categories”.

The International Probiotics Association is a global non-profit organization that brings together, through its membership, participants in the probiotic sector including academia, scientists, healthcare professionals, consumers, industry and legislators. The mission of the International Probiotics Association is to promote the safe and effective use of probiotics worldwide. Having pre­Codex Alimentarius non­governmental organization status and ISO observer status, IPA is also recognized as the unique "global voice of probiotics" worldwide.

www.internationalprobiotics.org